Advertisement Press Releases Archive - Page 99 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Quintiles Recognised as Industry Leader in Phase II/III Research for Second Year in a Row

    For the second year in a row, Quintiles has been named the industry leader that best differentiates itself on service quality for Phase II/III research in Industry Standard Research’s (ISR) 2014 CRO Quality Benchmarking Phase II/III Service Providers Report. According to the 148 pharmaceutical and biotechnology decision makers surveyed by ISR in this year’s report, Quintiles is the preferred provider for Phase II/III research among small, mid-size and large biopharmaceutical companies.

  • PRA is Named International Clinical Company Of The Year

    PRA Health Sciences (PRA) is pleased to announce that it was named Clinical Company of the Year at the International Clinical Researcher of the Year award ceremony in London. This is the second year in a row that PRA has won this prestigious award. PRA also swept the Clinical Team of the Year category. PRA winners include:

  • PRA Health Sciences To Add New Jobs In Swansea

    PRA Health Sciences (PRA), a leading global clinical research organization, is expanding its business in Swansea with the creation of 87 new jobs. The expansion will be supported by £990,060 of business finance from the Welsh Government enabling PRA to grow its local workforce to 280 by December 2017.

  • Helping Nepal – SHL to Match Staff Donations

    In immediate response to the devastating earthquake that left Nepal in ruins on April 25th, SHL quickly reached out to World Vision to hold an internal donation event at its key manufacturing sites in Taiwan where a booth is being set up for staff to contribute in any amount possible. SHL employees at regional offices in Sweden, USA and China have also all joined in the company’s efforts through World Vision International or their respective channels.

  • SHL to Speak and Exhibit at the Prefilled Syringe Seminar 2015 Tokyo

    SHL will be attending and exhibiting at the upcoming Guide for Prefilled Syringe Seminar 2015 in Tokyo, Japan, where Executive Director of Business Development Thomas Schönknecht has been invited to speak on the topic of "Insight Into the Changing World of Auto Injectors: Trends, Partnerships and Key Learnings."

  • SHL Group Introduces new Corporate Website

    To enhance the user experience of our corporate website and to better support our group companies including SHL Medical, SHL Healthcare, SHL Technologies and SHL Pharma, SHL Group is proud to introduce our newest corporate website.